← Back to Screener
Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Price$19.40
Value ScoreD
Growth ScoreA
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-36.02%
Price vs S&P 500 (4W)-7.83%
VGM Score52.75
Market Capitalization$1.13B
All Metrics
Book Value / Share (Quarterly)$4.94
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.04
Price vs S&P 500 (YTD)-35.01%
Gross Margin (TTM)48.75%
Net Profit Margin (TTM)-172.99%
EPS (TTM)$-2.80
10-Day Avg Trading Volume0.30M
EPS Excl Extra (TTM)$-2.80
EPS (Annual)$-2.30
ROI (Annual)-46.17%
Gross Margin (Annual)40.47%
Cash / Share (Quarterly)$4.99
Revenue Growth QoQ (YoY)62.70%
ROA (Last FY)-38.48%
Revenue Growth TTM (YoY)59.06%
EBITD / Share (TTM)$-2.60
Operating Margin (TTM)-171.53%
Cash Flow / Share (Annual)$-2.03
P/B Ratio3.93x
P/B Ratio (Quarterly)5.07x
Net Income / Employee (Annual)$-344,900
EV / Revenue (TTM)10.55x
Net Interest Coverage (TTM)-24.07x
ROA (TTM)-48.76%
EPS Incl Extra (Annual)$-2.30
Current Ratio (Annual)6.72x
Quick Ratio (Quarterly)7.28x
3-Month Avg Trading Volume0.33M
52-Week Price Return-2.81%
Revenue / Employee (TTM)$253,700
P/S Ratio (Annual)18.93x
Asset Turnover (Annual)0.20x
52-Week High$30.00
EPS Excl Extra (Annual)$-2.30
26-Week Price Return-28.09%
Quick Ratio (Annual)6.69x
13-Week Price Return-18.14%
Total Debt / Equity (Annual)0.20x
Current Ratio (Quarterly)7.32x
Enterprise Value$883.38M
Asset Turnover (TTM)0.28x
Revenue / Employee (Annual)$181,300
Pretax Margin (Annual)-190.05%
Cash / Share (Annual)$4.80
3-Month Return Std Dev76.50%
Net Income / Employee (TTM)$-438,900
ROE (Last FY)-55.41%
Net Interest Coverage (Annual)-76.35x
EPS Basic Excl Extra (Annual)$-2.30
Receivables Turnover (TTM)8.11x
Total Debt / Equity (Quarterly)0.15x
EPS Incl Extra (TTM)$-2.80
ROI (TTM)-57.45%
P/S Ratio (TTM)13.53x
Revenue / Share (Annual)$1.21
Price vs S&P 500 (52W)-27.17%
Year-to-Date Return-26.85%
5-Day Price Return-3.91%
EPS Normalized (Annual)$-2.30
Net Profit Margin (Annual)-190.28%
Month-to-Date Return-8.75%
EBITD / Share (Annual)$-1.99
Operating Margin (Annual)-177.85%
LT Debt / Equity (Annual)0.20x
LT Debt / Equity (Quarterly)0.15x
EPS Basic Excl Extra (TTM)$-2.80
P/B Ratio (Annual)6.01x
Pretax Margin (TTM)-171.62%
Book Value / Share (Annual)$4.15
Price vs S&P 500 (13W)-26.40%
Beta2.27x
Revenue / Share (TTM)$1.50
ROE (TTM)-68.83%
52-Week Low$13.25
vGradeD
gGradeA
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.31
4.31
4.31
4.31
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
KMTSKestra Medical Technologies, Ltd. Common Stock | D | A | C | $19.40 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Kestra Medical Technologies is a commercial-stage company developing wearable medical devices and digital healthcare solutions for cardiovascular disease management. Its Cardiac Recovery System platform integrates monitoring, therapy, digital health, and patient support into a unified solution centered on the ASSURE WCD, a wearable cardioverter defibrillator designed to prevent sudden cardiac arrest in high-risk patients. The company targets a significant clinical need by combining advanced wearable technology with connected digital services for cardiac care.